<DOC>
	<DOCNO>NCT00003185</DOCNO>
	<brief_summary>RATIONALE : Biological therapy use different way stimulate immune system stop cancer cell grow . PURPOSE : Phase II trial study effectiveness biological therapy treat patient glioblastoma multiforme .</brief_summary>
	<brief_title>Biological Therapy Treating Patients With Glioblastoma Multiforme</brief_title>
	<detailed_description>OBJECTIVES : I . Determine time progression patient glioblastoma multiforme anaplastic astrocytoma ( primary presentation ) treat surgical resection , radiotherapy , T cell immunotherapy initial therapy . II . Determine toxic effect therapy patient . OUTLINE : Patients vaccinate irradiated , autologous tumor cell plus sargramostim ( GM-CSF ) intradermally near drain lymph node groin axillary region . This follow 3 consecutive day intradermal injection GM-CSF , directly vaccine site . Enlarged lymph node remove 7-10 day later activate staphylococcal enterotoxin A ( SEA ) interleukin-2 ( IL-2 ) . T cell expand ex vivo approximately 10 day . 1-2 day prior infusion , oral cyclophosphamide administer one time dose . The lymphocyte infusion administer intravenously . Based availability , patient may receive vaccine boost additional injection irradiate autologous tumor cell thaw original , cryopreserved collection . Patients follow 1 month every 2 month thereafter . PROJECTED ACCRUAL : A maximum 40 patient accrue study within 2 year .</detailed_description>
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically proven glioblastoma multiforme anaplastic astrocytoma Prior surgical resection radiotherapy complete approximately 1 month prior study PATIENT CHARACTERISTICS : Age : Over 18 Performance status : ECOG 01 OR Karnofsky 70100 % Life expectancy : Not specify Hematopoietic : WBC great 2000/mm3 Platelet count great 100,000/mm3 Hepatic : No active infection hepatitis B Renal : Not specify Other : Not pregnant nursing Fertile patient must use effective contraception 1 month study No active collagen vascular autoimmune disease No prior severe reaction blood product No prior malignancy within past 5 year except adequately treat squamous cell basal cell skin cancer , carcinoma situ cervix , stage I II cancer complete remission Not immunologically compromise due chronic condition Not allergic standard skin test HIV negative PRIOR CONCURRENT THERAPY : Biologic therapy : No concurrent biologic therapy immunomodulatory effect ( e.g. , interleukin2 , interferon alfa ) Chemotherapy : No prior concurrent local systemic chemotherapy Endocrine therapy : At least 1 week since prior corticosteroid therapy No concurrent corticosteroid therapy Radiotherapy : See Disease Characteristics Surgery : See Disease Characteristics Other : No concurrent antiproliferatives immunosuppressant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2008</verification_date>
	<keyword>adult glioblastoma</keyword>
	<keyword>adult anaplastic astrocytoma</keyword>
	<keyword>adult giant cell glioblastoma</keyword>
	<keyword>adult gliosarcoma</keyword>
</DOC>